You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 18, November 14, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (29)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Colon Cancer
 •Quality of Care
 •Quality of Care, Other
 •Surgery
 •Surgical Interventions
 •Colorectal Surgery
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hospital Lymph Node Examination Rates and Survival After Resection for Colon Cancer

Sandra L. Wong, MD, MS; Hong Ji, MS; Brent K. Hollenbeck, MD, MS; Arden M. Morris, MD, MPH; Onur Baser, PhD; John D. Birkmeyer, MD

JAMA. 2007;298(18):2149-2154.

Context  Several studies suggest improved survival among patients in whom a higher number of nodes are examined after colectomy for colon cancer. The National Quality Forum and other organizations recently endorsed a 12-node minimum as a measure of hospital quality.

Objective  To assess whether hospitals that examine more lymph nodes after resection for colon cancer have superior late survival rates.

Design, Setting, and Patients  Retrospective cohort study, using the national Surveillance, Epidemiology, and End Results (SEER)–Medicare linked database (1995-2005), of US patients undergoing colectomy for nonmetastatic colon cancer (n = 30 625). Hospitals were ranked according to the proportion of their patients in whom 12 or more lymph nodes were examined and then were sorted into 4 evenly sized groups. Late survival rates were assessed for each hospital group, adjusting for potentially confounding patient and clinician characteristics.

Main Outcome Measures  Hospitals' lymph node examination rates in association with cancer staging, use of adjuvant chemotherapy (indicated for patients with node-positive disease), and 5-year survival rate.

Results  Hospitals with the highest proportions of patients with examination of 12 or more lymph nodes tended to treat lower-risk patients and had substantially higher procedure volumes. After adjusting for these and other factors, there remained no statistically significant relationship between hospital lymph node examination rates and survival after surgery (adjusted hazard ratio, highest vs lowest hospital quartile, 0.95; 95% confidence interval, 0.88-1.03). Although the 4 hospital groups varied widely in the number of lymph nodes examined, they were equally likely to find node-positive tumors and had very similar overall unadjusted rates of adjuvant chemotherapy (26% vs 25%, highest vs lowest hospital quartile).

Conclusions  The number of lymph nodes hospitals examine following colectomy for colon cancer is not associated with staging, use of adjuvant chemotherapy, or patient survival. Efforts by payers and professional organizations to increase node examination rates may have limited value as a public health intervention.


Author Affiliations: Michigan Surgical Collaborative for Outcomes Research and Evaluation, Departments of Surgery (Drs Wong, Morris, Baser, Birkmeyer, and Ms Ji) and Urology (Dr Hollenbeck), University of Michigan, Ann Arbor.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Lymph Node Examination Rate, Survival Rate, and Quality of Care in Colon Cancer
, , , and
JAMA. ;299():896-896.
FULL TEXT  

Lymph Node Examination Rate, Survival Rate, and Quality of Care in Colon Cancer
, , , and
JAMA. ;299():896-897.
FULL TEXT  

RELATED ARTICLE

Lymph Node Counts in Colon Cancer Surgery: Lessons for Users of Quality Indicators
and
JAMA. ;298():2194-2195.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased Lymph Node Evaluation With Colorectal Cancer Resection: Does It Improve Detection of Stage III Disease?
Kukreja et al.
Arch Surg 2009;144:612-617.
ABSTRACT | FULL TEXT  

Lymph Node Evaluation as a Colon Cancer Quality Measure: A National Hospital Report Card
Bilimoria et al.
JNCI J Natl Cancer Inst 2008;100:1310-1317.
ABSTRACT | FULL TEXT  

American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures
Desch et al.
JCO 2008;26:3631-3637.
ABSTRACT | FULL TEXT  

The Staging of Cancer: A Retrospective and Prospective Appraisal
Greene and Sobin
CA Cancer J Clin 2008;58:180-190.
ABSTRACT | FULL TEXT  

Lymph Node Examination Rate, Survival Rate, and Quality of Care in Colon Cancer
Bilimoria et al.
JAMA 2008;299:896-896.
FULL TEXT  

Lymph Node Examination Rate, Survival Rate, and Quality of Care in Colon Cancer
Peters et al.
JAMA 2008;299:896-897.
FULL TEXT  

Lymph-Node Counts in Colorectal Cancer Surgical Specimens Challenged as Quality Indicator
JWatch Gastroenterology 2007;2007:1-1.
FULL TEXT  

Lymph Node Counts in Colon Cancer Surgery: Lessons for Users of Quality Indicators
Simunovic and Baxter
JAMA 2007;298:2194-2195.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.